Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -33.73% is 54% above its 5-year average of -72.79%, near the high end of its 5-year range (-420.68%–-29.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 56.41% above its 12-month average of -77.39%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -33.73%.
RETURN ON INVESTED CAPITAL (ROIC)
-33.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-77.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-70.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-72.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.41%
CURRENT VS 3Y AVG
+52.45%
CURRENT VS 5Y AVG
+53.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.19%
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-24.07%
vs the sector median at left
Aprea Therapeutics, Inc.
Market Cap
$8.37M
Return on Invested Capital (ROIC)
-33.73%
TTM Avg
-77.39%
3Y Avg
-70.94%
5Y Avg
-72.79%
Market Cap
$8.76M
Return on Invested Capital (ROIC)
-11.06%
TTM Avg
-74.47%
3Y Avg
-55.02%
5Y Avg
-81.57%
Market Cap
$7.77M
Return on Invested Capital (ROIC)
-457.75%
TTM Avg
-214.65%
3Y Avg
-192.14%
5Y Avg
-209.63%
Market Cap
$7.75M
Return on Invested Capital (ROIC)
-92.94%
TTM Avg
-279.36%
3Y Avg
-244.50%
5Y Avg
-201.18%
Market Cap
$9.09M
Return on Invested Capital (ROIC)
-21.90%
TTM Avg
-47.33%
3Y Avg
-176.82%
5Y Avg
-106.87%
Market Cap
$9.42M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-174.21%
3Y Avg
-638.36%
5Y Avg
-516.05%
Market Cap
$7.03M
Return on Invested Capital (ROIC)
-208.39%
TTM Avg
-54.78%
3Y Avg
-47.23%
5Y Avg
-47.23%
Market Cap
$9.79M
Return on Invested Capital (ROIC)
-80.51%
TTM Avg
-60.18%
3Y Avg
-50.63%
5Y Avg
-247.68%
Market Cap
$6.88M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-109.13%
3Y Avg
-72.14%
5Y Avg
-33.59%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | $8.37M | -33.73% | -77.39% | -70.94% | -72.79% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.76M | -11.06% | -74.47% | -55.02% | -81.57% |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | -457.75% | -214.65% | -192.14% | -209.63% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -92.94% | -279.36% | -244.50% | -201.18% |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | -21.90% | -47.33% | -176.82% | -106.87% |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A | -174.21% | -638.36% | -516.05% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -208.39% | -54.78% | -47.23% | -47.23% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -80.51% | -60.18% | -50.63% | -247.68% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -219.15% | -109.13% | -72.14% | -33.59% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -107.99% | -407.39% | -445.97% | -342.27% |
ROIC
-33.7%
ROE
-32.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -33.73% |
| 2026-03-31 | -29.38% |
| 2025-12-31 | -100.49% |
| 2025-09-30 | -118.70% |
| 2025-06-30 | -104.63% |
| 2025-03-31 | -90.48% |
| 2024-12-31 | -69.45% |
| 2024-09-30 | -63.50% |
| 2024-06-30 | -52.83% |
| 2024-03-31 | -46.30% |
| 2023-12-31 | -84.71% |
| 2023-09-30 | -66.89% |
| 2023-06-30 | -61.16% |
| 2023-03-31 | -395.57% |
| 2022-12-31 | -420.68% |
| 2022-09-30 | -400.25% |
| 2022-06-30 | -375.15% |
| 2022-03-31 | -81.00% |
| 2021-12-31 | -75.64% |
| 2021-09-30 | -82.03% |
| 2021-06-30 | -76.53% |
| 2021-03-31 | -73.91% |
| 2020-12-31 | -68.17% |
| 2020-09-30 | -56.72% |
| 2020-06-30 | -45.41% |
| 2020-03-31 | -32.58% |
| 2019-12-31 | -23.72% |
| 2019-09-30 | -47.04% |
| 2019-06-30 | -32.16% |
